Larvol Delta - RESETSSc-Phase-12-cohort-patients-showed-overall-improvement-in-skin-and-lung-disease-activity-and-achieved-clinical-responses-while-off-IMs-and-off-or-tapering-steroids-that-appear-to-improve-with-longer-followup

resecabtagene autoleucel (CABA-201) - Cabaletta Bio

https://www.globenewswire.com/news-release/2026/06/03/3305899/0/en/cabaletta-bio-announces-new-rese-cel-data-and-development-updates-across-autoimmune-portfolio-including-encouraging-early-pc-free-lupus-findings-at-eular-2026-congress.html

Jun 3, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next